Zacks Investment Research
16 Jul 2026, 16:46 UTC · 1h ago
Smith+Nephew Launches LYNX COBLATION Wand for ENT Airway Surgery
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
16 Jul 2026, 16:46 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
Smith+Nephew (SNN) has commercially launched the LYNX COBLATION Laryngeal Wand for ENT airway procedures. — The introduction of a new, versatile medical device expands the company's product portfolio and creates a new revenue stream in the ENT market.
+0.30SNN shares rose 3.3% following the announcement of the LYNX Wand launch. — Immediate positive price action indicates a favorable initial market reception to the product news.
+0.10Which stocks this story touches
The company launched a new surgical device (LYNX COBLATION Laryngeal Wand) that is expected to drive growth and expanded clinical adoption.
Continue reading
6 related stories
Top 1 mover · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
4h ago
